Delivery Order SPE2DR25D2012-SPE2DR26F1BMR
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a $10,413.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IPOL Vial 5ML, a polio vaccine product. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- This delivery order, valued at $72,979.90 with an ultimate completion date of November 3, 2025, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML, a polio vaccine product. The contract employs firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of IPOL Vial 5ML, a polio vaccine product. This competitively awarded, non-set-aside contract carries a ceiling value of $5,437.76 with firm fixed pricing and an ultimate completion date of August 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,486.01 to AmerisourceBergen Drug Corp for the supply of Ipol Vial 5ML, an inactivated polio vaccine. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 5, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,563.97 for IPOL Vial 5ML pharmaceutical products on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilizes firm fixed-price contract terms and represents a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML pharmaceutical product, with a ceiling value of $1,544.12. This competitive award, issued on September 14, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BMRDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,230.88 firm fixed-price delivery order by the Defense Logistics Agency on December 8, 2025, for IPOL vial 5ML (inactivated polio vaccine). This competitive award, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order exemplifies AmerisourceBergen's role as a critical federal medical supply vendor for the Department of Defense healthcare ecosystem. The company's comprehensive IDC vehicle enables it to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of IPOL vaccine vials supports military healthcare programs and demonstrates the contractor's continued capability to meet federal immunization and medical supply needs through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/7/25 |